• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 8 of 38
A health care worker comforts a COVID-19 patient in Houston.
HealthWe were promised Pfizer pills. Where are the other COVID treatments?
By Nicole GoodkindJanuary 11, 2022
A man receives a fourth dose of COVID-19 vaccine at Sheba Medical Center in central Israeli city of Ramat Gan on Dec. 31, 2021.
HealthPushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By David MeyerJanuary 11, 2022
Pfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
HealthPfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
By Riley Griffin and BloombergJanuary 10, 2022
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
HealthWith Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
By Erika Fry and Nicolas RappJanuary 5, 2022
CDC panel approves booster shots for young teens
HealthCDC panel approves Pfizer boosters for younger teens
By Lauran Neergaard, Mike Stobbe and The Associated PressJanuary 5, 2022
Pfizer booster eligibility
HealthFDA clears Pfizer boosters for 12-to-15 year-olds
By Lauran Neergaard and The Associated PressJanuary 3, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
FinanceOmicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By Jeremy KahnDecember 29, 2021
A health care worker prepares a Moderna booster vaccine dose.
HealthModerna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
Merck covid 19 pill
HealthFDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
Pfizer logo pill
HealthPfizer pill becomes first FDA-approved home COVID treatment
By Matthew Perrone and The Associated PressDecember 22, 2021
COVID-19 vaccine in front of Israeli flag
HealthIsrael to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters
By David MeyerDecember 22, 2021
COVID-19 pill
HealthFDA set to authorize Pfizer and Merck COVID pills this week
By Josh Wingrove, Jennifer Jacobs, Robert Langreth and BloombergDecember 21, 2021
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
HealthEU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
HealthEurope taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
By Christiaan HetznerDecember 17, 2021
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
HealthJ&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By BloombergDecember 17, 2021
1...
  • 6
  • 7
  • 8
  • 9
  • 10
...38
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Ex-Google engineer says Larry Page, Sergey Brin and Sundar Pichai share the same trait—it's the lesson he swears by as a $7.2 billion AI CEOplaceholder alt text
By Orianna Rosa RoyleJune 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.